VOR
Vor BiopharmaCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
Current thesis
The post-earnings company update was operationally constructive: Vor reiterated that both global Phase 3 programs are progressing, kept UPSTREAM MG topline timing in 1H27, and reported cash runway into early 2029. The March 2026 private placement also added $74.9 million of net proceeds and reduced near-term financing pressure [#8-K-2026-03-27][#10-Q-2026-05-13].
Posture
Mixed
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta +13.1.
What can break
Clinical and regulatory failure in UPSTREAM MG or UPSTREAM SjD would likely impair most of the equity story because Vor is now primarily centered on telitacicept.
Momentum
89
Value
41
Sentiment
34
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $15.00 · Bull $24.00 · Bear $9.00
Data freshness
Prices
As of 2026-07-20
Fundamentals
As of 2026-07-20 • Vendor: Data Vendor v1
Scores
As of 2026-07-20 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-16 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-20
Investment thesis
As of 2026-07-20
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $37.88
Why
Momentum89 · Δ7d +13.1
Value41 · Δ7d +0.0
Sentiment34 · Δ7d +2.0
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Momentum · See technicals
Momentum
89
26% active weight
Current posture
7d trendImproving
Δ7d
+13.1
Δ21d
+66.1
Value
41
39% active weight
Current posture
7d trendFlat
Δ7d
+0.0
Δ21d
-0.1
Sentiment
34
34% active weight
Current posture
7d trendImproving
Δ7d
+2.0
Δ21d
-11.9
Why this grade
Composite grade C. Momentum 89.1 / Value 41.1 / Sentiment 33.6
Fundamentals (TTM)As of 2026-07-20
Fundamentals (TTM)
As of 2026-07-20
Market Cap
$945.54M
Beta
2.03
Shares Out
54.19M
P/E (TTM) · Derived
-0.2
P/S (TTM)
-
P/FCF (TTM) · Derived
-1.15
Rev YoY
-
EPS YoY
-1.9%
Gross Margin
-
Op Margin
-
Net Debt
-$452.21M
Current Ratio
31.15
As of 2026-07-20 • Updated nightlySource: Internal modelMethodology